+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Urticaria Drug"

Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Urticaria - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 80 Pages
  • Global
From
Chronic Spontaneous Urticaria Market Report 2024 - Product Thumbnail Image

Chronic Spontaneous Urticaria Market Report 2024

  • Report
  • August 2024
  • 175 Pages
  • Global
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
From
From
Chronic Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
Chronic Inducible Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Inducible Urticaria - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Chronic Idiopathic Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Idiopathic Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 100 Pages
  • Global
From
Chronic Urticaria Or Hives - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Chronic Urticaria Or Hives - Global Clinical Trials Review, 2024

  • Clinical Trials
  • July 2024
  • 458 Pages
  • Global
From
From
From
KPL-716 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KPL-716 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
LOU064 Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

LOU064 Emerging Drug Insight and Market Forecast - 2032

  • Report
  • September 2022
  • 30 Pages
  • Global
From
From
Chronic Urticaria Therapeutics - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Urticaria Therapeutics - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032 - Product Thumbnail Image

Chronic Spontaneous Urticaria (CSU) - Epidemiology Forecast - 2032

  • Drug Pipelines
  • January 2022
  • 100 Pages
  • Global
From
Chronic Idiopathic Urticaria - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic Idiopathic Urticaria - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Urticaria Drug market is a subset of the Immune Disorders Drugs market, which focuses on the treatment of allergic reactions and other immune-related conditions. Urticaria, also known as hives, is a common skin condition characterized by itchy, raised welts on the skin. Urticaria drugs are used to reduce the symptoms of the condition, such as itching, swelling, and redness. These drugs can be administered orally, topically, or intravenously, depending on the severity of the condition. Commonly used urticaria drugs include antihistamines, corticosteroids, and leukotriene receptor antagonists. Some companies in the Urticaria Drug market include GlaxoSmithKline, Sanofi, Novartis, Pfizer, and Merck. Show Less Read more